Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy

Rebuild a viable surface before improving optics

Ocular-surface reconstruction aims to produce a stable epithelial barrier, adequate protection and a usable optical surface. A transparent donor cornea cannot remain clear if the recipient lacks epithelial support, lid protection or a suitable tear environment. Separate the immediate problem—such as a persistent defect or threatened perforation—from the long-term reason it recurs. Assess lids, lashes, blink, tear function, sensation, limbal status, inflammation and infection before choosing a reconstructive procedure.

Limbal stem-cell deficiency (LSCD) impairs replenishment of corneal epithelium. Conjunctival epithelium can extend over the cornea, producing irregular staining, recurrent defects, superficial vessels and loss of transparency. Chemical or thermal burns, chronic inflammatory disease, aniridia-related disease and some iatrogenic injuries are causes. LSCD can be partial or total and unilateral or bilateral; these distinctions change the available donor source and risk.

Confirm the dominant failure mechanism

Clinical signs include an irregular conjunctivalised surface, loss of normal limbal features and late fluorescein staining patterns, but a vascularised scar alone does not establish LSCD. Impression cytology or other specialist tests can support the diagnosis. Distinguish epithelial failure from stromal scarring and endothelial oedema: several mechanisms may coexist, but each requires a different intervention.

Control active inflammation and improve lid closure and tear support before elective transplantation where possible. A keratinised lid margin can abrade newly reconstructed epithelium, while severe aqueous deficiency compromises survival. Infection must be addressed. The patient’s ability to manage medicines and attend frequent follow-up is part of the surgical assessment, not merely an administrative consideration.

Limbal transplantation and cultured cells

In unilateral disease, autologous limbal tissue or cultured autologous cells may be available from a sufficiently healthy donor area. Harvesting carries a risk to the donor eye, so the amount and method matter. Simple limbal epithelial transplantation and cultivated approaches are distinct techniques; neither name implies an identical protocol or success rate. Bilateral disease may require allogeneic tissue or another epithelial strategy, with systemic immunosuppression and rejection issues considered where appropriate.

Holoclar is an EU-authorised cultured autologous corneal epithelial-cell product containing stem cells. Its indication is adult moderate-to-severe LSCD due to physical or chemical burns, including unilateral or bilateral disease, and it requires a small area of undamaged limbus for biopsy. It is not authorised as a universal treatment for every inherited or immune-mediated surface disorder. The current EMA product overview also records its transition from conditional to standard authorisation in 2024. Manufacturing and implantation require specialist facilities and patient-specific handling.

A successful epithelial reconstruction does not remove a deep stromal scar. A later optical graft may be considered once the surface is sufficiently stable. Sequence interventions around the biology rather than attempting all corrective procedures simply because the eye is already in theatre.

Protective closure and amniotic membrane

Tarsorrhaphy reduces exposure by partially or more extensively closing the lids. Temporary and longer-term techniques are selected according to the cause and expected recovery. Preserve the access needed for examination and treatment. It can be valuable in exposure or neurotrophic disease but must not conceal an unmonitored infection or progressing melt. Explain the trade-off between protection and temporary restriction of the visual field or appearance.

Amniotic membrane can support epithelial healing and modulate surface inflammation or scarring. It may be used as a graft, patch or multilayer construct, with different aims and orientation requirements. A membrane alone does not replace missing limbal stem cells in total LSCD. Persistent epithelial failure after membrane placement should trigger reassessment of the driver rather than automatic repetition indefinitely.

Phototherapeutic keratectomy

PTK uses excimer photoablation to remove superficial tissue and smooth an irregular cornea. It differs from refractive PRK because the main goal is therapeutic tissue removal, although refractive change can still occur. Suitable examples include selected superficial scars, recurrent erosion and superficial deposits. Depth of pathology, corneal thickness, surface regularity and healing potential determine suitability. An active infection or severe uncontrolled surface disorder is not corrected by simply ablating the opacity.

Use masking techniques and ablation planning according to the lesion and platform rather than prescribing a universal number of micrometres. A smoother cornea may improve vision or comfort, but deeper opacity and irregular astigmatism can persist. After PTK, assess epithelial closure, infection, refractive change and recurrence.

A reconstructive decision

A burn survivor with total conjunctivalisation, severe dry eye and a stromal scar needs surface and lid rehabilitation before an optical graft is likely to succeed. A patient with a local superficial opacity and healthy sensation, tears and limbus may instead benefit from PTK. State which tissue function the proposed procedure restores and which limitations will remain; that explanation connects surgical choice to the examination rather than to a generic list of operations.